Aspen Aerogels, Inc. (NYSE:ASPN) Receives $18.44 Average PT from Brokerages

Aspen Aerogels, Inc. (NYSE:ASPN) has earned an average recommendation of “Moderate Buy” from the eleven research firms that are presently covering the company, MarketBeat.com reports. Three analysts have rated the stock with a hold rating, seven have assigned a buy rating and one has given a strong buy rating to the company. The average 12 month price target among brokerages that have updated their coverage on the stock in the last year is $18.44.

Several brokerages have recently issued reports on ASPN. Barclays reiterated an “equal weight” rating and set a $7.00 price objective (down from $13.00) on shares of Aspen Aerogels in a research report on Thursday, May 29th. Oppenheimer downgraded Aspen Aerogels from an “outperform” rating to a “market perform” rating in a research report on Thursday, May 8th.

Insider Activity at Aspen Aerogels

In other Aspen Aerogels news, CEO Donald R. Young acquired 20,000 shares of the firm’s stock in a transaction that occurred on Monday, May 12th. The stock was purchased at an average cost of $5.35 per share, for a total transaction of $107,000.00. Following the completion of the acquisition, the chief executive officer owned 550,856 shares of the company’s stock, valued at approximately $2,947,079.60. This trade represents a 3.77% increase in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. 4.30% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Aspen Aerogels

A number of hedge funds have recently bought and sold shares of the company. Bank of New York Mellon Corp lifted its stake in shares of Aspen Aerogels by 9.3% in the fourth quarter. Bank of New York Mellon Corp now owns 189,884 shares of the construction company’s stock valued at $2,256,000 after buying an additional 16,094 shares during the period. Charles Schwab Investment Management Inc. lifted its stake in shares of Aspen Aerogels by 7.9% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 549,709 shares of the construction company’s stock valued at $6,531,000 after buying an additional 40,279 shares during the period. Raymond James Financial Inc. bought a new stake in shares of Aspen Aerogels in the fourth quarter valued at about $2,909,000. AlphaQuest LLC lifted its stake in shares of Aspen Aerogels by 54.0% in the fourth quarter. AlphaQuest LLC now owns 11,395 shares of the construction company’s stock valued at $135,000 after buying an additional 3,998 shares during the period. Finally, Swiss National Bank lifted its stake in shares of Aspen Aerogels by 1.9% in the fourth quarter. Swiss National Bank now owns 128,800 shares of the construction company’s stock valued at $1,530,000 after buying an additional 2,400 shares during the period. 97.64% of the stock is currently owned by institutional investors.

Aspen Aerogels Stock Down 2.2%

Shares of Aspen Aerogels stock opened at $6.35 on Monday. The company has a quick ratio of 3.53, a current ratio of 4.22 and a debt-to-equity ratio of 0.40. The firm has a market cap of $520.99 million, a P/E ratio of -1.82 and a beta of 2.65. Aspen Aerogels has a fifty-two week low of $4.16 and a fifty-two week high of $33.15. The business has a 50-day moving average price of $6.13 and a 200 day moving average price of $7.67.

Aspen Aerogels (NYSE:ASPN) last announced its quarterly earnings data on Thursday, May 8th. The construction company reported ($0.06) earnings per share for the quarter, beating the consensus estimate of ($0.07) by $0.01. The firm had revenue of $78.72 million during the quarter, compared to analyst estimates of $82.75 million. Aspen Aerogels had a positive return on equity of 6.69% and a negative net margin of 65.47%. Aspen Aerogels’s quarterly revenue was down 16.7% on a year-over-year basis. During the same period in the previous year, the company earned ($0.02) earnings per share. On average, sell-side analysts forecast that Aspen Aerogels will post 0.17 earnings per share for the current fiscal year.

About Aspen Aerogels

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.